The bench blog
Field notes with receipts.
Everything published here runs on the same open dataset you can download, and clinical claims wait for a physician's sign-off before any badge appears. If a post can't cite its receipts, it doesn't ship.
Lead story
Cheapest Compounded Tirzepatide Online: We Shopped Six Programs — Here Are the Year-One Receipts
Month one, month seven, and the exit — receipts from six checkouts, the ~$1,080 step-up tax quantified, the 2026 legal lane in two paragraphs, and the three trial results that explain the demand. MEDICALLY REVIEWED · AUG 17, 2026
~2,400 words · updated Aug 17, 2026 · raw data
Latest from the queue
Microdosing GLP-1s: A Fair Hearing for an Unproven Idea
The tolerability case, the dose-response math, and exactly where the trial record ends — with the only audited microdose prices in the field. MEDICAL SIGN-OFF PENDING
Hims vs Henry Meds: The Price of the Door
Commitment discount vs exit freedom, broken even at month eight — with the audited benchmark that sits below both. MEDICAL SIGN-OFF PENDING
SURMOUNT-5, Beyond the Headline
What 20.2% vs 13.7% actually compared — and the $240/year the gap costs at audited prices. MEDICAL SIGN-OFF PENDING
Stopping Tirzepatide: The Off-Ramp
SURMOUNT-4's regain data turned into a plan — muscle first, tripwires in writing, re-entry priced. MEDICAL SIGN-OFF PENDING
B12, Glycine, L-Carnitine: The Additive Audit
Why the vitamins are marketing, and the salt-form warning that isn't. MEDICAL SIGN-OFF PENDING
Stopping Semaglutide: The Extension Data
Two-thirds regained in the year off — and the sema-specific plan that respects it. MEDICAL SIGN-OFF PENDING
Tirzepatide: 60 Questions Answered
The answer bank — dosing to dollars, every answer sourced and schema-wired. MEDICAL SIGN-OFF PENDING
Semaglutide: 40 Questions Answered
The sister bank — STEP to salt forms to the $110 audited floor. MEDICAL SIGN-OFF PENDING
"From" Pricing Decoded
Eight qualifier instruments, field examples, and the ten-second parser. PRICING ANALYSIS
SURMOUNT-1, Reread
The 20.9% pivotal decomposed — plus the ~94% diabetes-prevention extension. MEDICAL SIGN-OFF PENDING
The Titration Ladder, Annotated
Every rung, "as tolerated" decoded — and what each step costs where pricing tiers. MEDICAL SIGN-OFF PENDING
First-Month Discounts, Annualized
The $99 door priced honestly: $2,288–$3,388 years, worked on the record. PRICING ANALYSIS
Muscle & Protein on GLP-1s
The DXA reality and the two-part counter-program that actually works. MEDICAL SIGN-OFF PENDING
STEP 1, Reread
The era-starter — and why it still wins dollars-per-percent at $1,428. MEDICAL SIGN-OFF PENDING
Prepay Refund Policies
The taxonomy from pro-rata to silence — and the $399-on-$133 effective-price math. PRICING ANALYSIS
Oral Semaglutide, Explained
SNAC chemistry, the 4-oz ritual, OASIS' 50 mg future — and the drops that skip the science. MEDICAL SIGN-OFF PENDING
The Pharmacokinetics of Forgiveness
Two half-lives, every rule derived: windows, rungs, travel, the long tail. MEDICAL SIGN-OFF PENDING
The Savings-Card Decoder
Tiers, caps, and the accumulator trap that eats deductibles quietly. PRICING ANALYSIS
Retatrutide, Tracked
The 24% triple agonist — and why every vial for sale today is a chemistry experiment. MEDICAL SIGN-OFF PENDING
Cold-Chain & the Porch Problem
Label windows, summer physics, and five written questions before anything ships. MEDICAL SIGN-OFF PENDING
The Semaglutide Switch Guide
Both directions mapped — no washout, honest resets, and where switches actually break. MEDICAL SIGN-OFF PENDING
The Red-Flags Field Manual
Fifteen tells, five categories, four instant disqualifiers — run it in ninety seconds. CONSUMER PROTECTION
Anatomy of a Winning Appeal
Four denial species, the five-part letter, and the external review nobody uses. COVERAGE ANALYSIS
Verify the Pharmacy Yourself
The five-link chain from public records — including the your-state check everyone skips. CONSUMER PROTECTION
Vial Math
One equation, five classic mistakes, and the FDA's 5–20× error reports. MEDICAL SIGN-OFF PENDING
Wegovy vs Compounded: $380/mo
Both cases at full strength — and the four-question sorter that makes the verdict yours. MEDICAL SIGN-OFF PENDING
Telehealth Law 101
The five-layer stack under every legitimate program — Ryan Haight myth retired. LEGAL ANALYSIS
Reading a COA
Four assays, gating metadata, ranked flags — five minutes to a verdict. MEDICAL SIGN-OFF PENDING
The Two-Line Price
Membership forensics: the fraction with a hidden denominator, totaled honestly. PRICING ANALYSIS
Autoship Law, Post-Vacatur
Click-to-cancel fell in 2025 — ROSCA and state ARLs are the real stack. LEGAL ANALYSIS
The 90-Day Fill Question
BUD clocks, the titration trap, and when bulk genuinely wins. MEDICAL SIGN-OFF PENDING
The SELECT Decoder
Who the CV claim covers — relative, absolute, and the NNT nobody quotes. MEDICAL SIGN-OFF PENDING
The Informed-Consent Teardown
Eight findable clauses — and the placement red flags that confess everything. LEGAL ANALYSIS
The Step-Down Lane
Tirzepatide results on semaglutide prices — the evidence map, drawn precisely. MEDICAL SIGN-OFF PENDING
The Two-Vial Month
Depletion tax, waste tax, dose-proof — three architectures under “monthly.” PRICING ANALYSIS
The Chargeback Ladder, Expanded
Five rungs, the right framings — and what the tool isn't for. CONSUMER PROTECTION
A ToS in Ten Minutes
Eight Ctrl-F searches, one expiring opt-out, and the calibration that matters. LEGAL ANALYSIS
GIP, Explained
The disgraced hormone's redemption arc — settled at the scoreboard, live at the mechanism. MEDICAL SIGN-OFF PENDING
Food Noise
The symptom patients named first — known vs plausible, the quieting and the return. MEDICAL SIGN-OFF PENDING
The Gallbladder File
The risk that rides the speed — symptom literacy and the go-now triad. MEDICAL SIGN-OFF PENDING
Pricing Archaeology
Four strata from shortage valve to the 2026 proposal — and how to read the fossils. MARKET ANALYSIS
Titration Holds
The art of staying put — and the hold-vs-quit line that saves therapies. MEDICAL SIGN-OFF PENDING
Zepbound Vials, Decoded
The $349-entry brand cash lane — what it keeps, surrenders, and competes with. PRICING ANALYSIS
Nausea Engineering
The comfort protocol from mechanics, not folklore — plus the red lines. MEDICAL SIGN-OFF PENDING
The Plateau Audit
Six causes in order — including the plateau that means it worked. MEDICAL SIGN-OFF PENDING
The SURMOUNT-OSA File
First-ever sleep-apnea indication — AHI decoded, CPAP answered, coverage door opened. MEDICAL SIGN-OFF PENDING
Reading “Best Of” Lists
Five tells, a sixty-second audit — run here on this site first. CONSUMER PROTECTION
In the audit queue — from the 250-topic research plan
- Fifty 410, Audited: What the ~$133 Prepay Really Buys — the field's lowest sticker, stress-tested.
- Zepbound Savings Card 2026: The $25 Path and Who Qualifies — the cases where brand wins outright.
- Tirzepatide vs Retatrutide: Reading the Triple-Agonist Data — what Phase 3 does and doesn't show.
- The Shipping Map: Which States Each Program Actually Serves — closing the field's biggest open file.
Posts ship when their numbers survive an audit, not on a calendar. The full research plan spans 250 topics, weighted roughly 60% tirzepatide / 40% semaglutide.